Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury

NCT: NCT03575169 · COMPLETED

NCT IDNCT03575169
StatusCOMPLETED
Start Date2019-07-01
Completion2022-12-31
SponsorUniversity of Aberdeen (OTHER)
First posted
Last updated

Brief Summary

An observational study to assess the BIS reported level of sedation of patients with traumatic brain injury in the ICU.

Frequently Asked Questions

What is The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury?

The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury is a clinical trial registered under NCT03575169. Current status: COMPLETED.

What is the status of NCT03575169?

The current status of NCT03575169 (The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury) is: COMPLETED.

When did The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury start?

The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury started on 2019-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.